COYA: Coya Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 92.55
Enterprise Value ($M) 61.49
Book Value ($M) 32.01
Book Value / Share 2.10
Price / Book 2.89
NCAV ($M) 31.96
NCAV / Share 2.10
Price / NCAV 2.90

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.90
Return on Equity (ROE) -1.06

Liquidity (mrq)
Quick Ratio 15.31
Current Ratio 15.31

Balance Sheet (mrq) ($M)
Current Assets 35.51
Assets 35.55
Liabilities 3.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-12 13G/A Vanguard Group Inc 5.55 0.00
02-14 13G/A Greenlight Capital Inc 8.80 -0.39
02-07 13G/A Hirschman Orin 8.10 68.17

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 12,201 67,851 17.98
2024-11-21 7,828 45,210 17.31
2024-11-20 5,717 36,549 15.64
2024-11-19 7,571 70,688 10.71

(click for more detail)

Similar Companies
COCP – Cocrystal Pharma, Inc. COEP – Coeptis Therapeutics Holdings, Inc.
CORT – Corcept Therapeutics Incorporated CPRX – Catalyst Pharmaceuticals, Inc.
CRBP – Corbus Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io